TERRY HUNTER: Open Payments
NPI 1588321020 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$392 in 16 payments from 7 companies in 2025. Trend: 2023 $540 · 2024 $216 · 2025 $392
Food & beverage: $392
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $152 |
| Alkermes, Inc. | 4 | $96 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
Products named: COBENFY, ARISTADA, FANAPT, JOURNAVX, INGREZZA, UZEDY, ABILIFY ASIMTUFII.
Industry payments across MI — which companies pay providers there.
